Search

Your search keyword '"Hagopian W"' showing total 240 results

Search Constraints

Start Over You searched for: Author "Hagopian W" Remove constraint Author: "Hagopian W"
240 results on '"Hagopian W"'

Search Results

1. Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: Metabolic and immunologic features at baseline identify a subgroup of responders

2. Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children

5. Two-age islet-autoantibody screening for childhood type 1 diabetes:a prospective cohort study

6. Islet autoantibody type-specific titer thresholds improve stratification of risk of progression to type 1 diabetes in children

7. HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children

8. Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories

10. Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories

11. Type 1 diabetes can present before the age of 6 months and is characterized by autoimmunity and rapid loss of beta cells

12. Early probiotic supplementation and the risk of celiac disease in children at genetic risk

14. Modeling Disease Progression Trajectories from Longitudinal Observational Data

17. Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort

23. Maternal dietary supplement use and development of islet autoimmunity in the offspring: TEDDY study

26. Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children

29. Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study

31. Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies

32. Dietary intake of soluble fiber and risk of islet autoimmunity by 5 y of age: Results from the TEDDY study

33. Methods, Quality Control and Specimen Management in an International Multi-Center Investigation of Type 1 Diabetes: TEDDY

34. Plasmid-Encoded Proinsulin Preserves C-Peptide While Specifically Reducing Proinsulin-Specific CD8+ T Cells in Type 1 Diabetes

35. Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients

36. Next-generation sequencing for viruses in children with rapid-onset type 1 diabetes

37. Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes.

38. Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment.

42. Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes.

43. A large sample of finnish diabetic sib-pairs reveals no evidence for a non-insulin-dependent diabetes mellitus susceptibility locus at 2qter.

Catalog

Books, media, physical & digital resources